Adenylyl Cyclase Signaling in the Developing Chick Heart: The Deranging Effect of Antiarrhythmic Drugs
Author(s) -
Lucie Hejnová,
Klára Hahnová,
Radka Kočková,
Jarmila Svatunkova,
David Sedmera,
Jiřı́ Novotný
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/463123
Subject(s) - adenylyl cyclase , forskolin , carvedilol , metoprolol , contractility , gs alpha subunit , signal transduction , medicine , endocrinology , embryonic heart , pharmacology , gene isoform , chemistry , microbiology and biotechnology , biology , receptor , embryonic stem cell , heart failure , biochemistry , gene
The adenylyl cyclase (AC) signaling system plays a crucial role in the regulation of cardiac contractility. Here we analyzed the key components of myocardial AC signaling in the developing chick embryo and assessed the impact of selected β -blocking agents on this system. Application of metoprolol and carvedilol, two commonly used β -blockers, at embryonic day (ED) 8 significantly downregulated (by about 40%) expression levels of AC5, the dominant cardiac AC isoform, and the amount of Gs α protein at ED9. Activity of AC stimulated by forskolin was also significantly reduced under these conditions. Interestingly, when administered at ED4, these drugs did not produce such profound changes in the myocardial AC signaling system, except for markedly increased expression of Gi α protein. These data indicate that β -blocking agents can strongly derange AC signaling during the first half of embryonic heart development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom